Overview

Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

To evaluate the efficacy of oral colchicine combined with intraoperative infusion of dexamethasone, low molecular weight heparin and 5-FU during vitrectomy for management of established proliferative vitreoretinopathy (PVR)

Phase:

Phase 3

Details

Lead Sponsor:

Shahid Beheshti University of Medical Sciences

Treatments:

BB 1101
Calcium heparin
Colchicine
Dalteparin
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Heparin
Heparin, Low-Molecular-Weight
Tinzaparin